DYNDyne Therapeutics, Inc.

$20.31

What is the market doing?

What the tape says about DYN

Dyne Therapeutics, Inc. is +65% over the past year while the S&P 500 is +20%: 44 points ahead of the market.

+65%

1-year return · S&P 500 +20%

vs 200-day average
+3.1%

vs 200-day average · close to trend

RSI (14)
18

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
24%

Below its 52-week high

2024-08-15$6.81 – $47.04 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$20.31
1 monthS&P 500 −0.30%
−22%
1 yearS&P 500 +20%
+65%
5 yearsS&P 500 +85%
+23%
vs 50-day average$23.63
−14%
52-week high
$26.80
52-week low
$11.97
Annualised volatility
84%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$227K
Calendar-year price return
YearReturn
2026 (year to date)+3.8%
2025−17%
2024+77%
2023+15%
2022−2.5%
2021−43%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan62 of 6−1.1%
Feb62 of 6+1.3%
Mar63 of 6−2.6%
Apr62 of 6−0.32%
May64 of 6+3.4%
Jun64 of 6+6.0%
Jul65 of 6+16%
Aug62 of 6+3.9%
Sep61 of 6−7.4%
Oct62 of 6+3.2%
Nov63 of 6+9.7%
Dec62 of 6−4.5%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.